Interstitial Lung Disease Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- You are between 18 and 75 years old.
- You have been diagnosed with Anti-synthetase Syndrome (a type of autoimmune condition) based on recognized 2017 medical guidelines.
- Scans of your lungs (a special type of CT scan) have confirmed that you have a lung condition called Interstitial Lung Disease (ILD), where the lung tissue becomes scarred or inflamed.
- Your condition is currently active and needs to be treated or treated more aggressively, and you have never previously taken steroids, immune-suppressing medicines, or biologic drugs for this condition.
- You are willing and able to sign a consent form agreeing to take part in the trial.
Who may not be able to join:
- You have a rapidly worsening form of the lung disease where breathing has gotten significantly worse within the last month and oxygen levels in your blood are very low (confirm with trial site).
- You have a serious active infection that is not under control, an active cancer, or a major organ (such as your heart, liver, or kidneys) that is not working properly.
- You are currently pregnant or breastfeeding.
- You have a medical reason why you cannot take the medicines being used in this trial (confirm with trial site).
- You are already taking immune-suppressing medicines or biologic drugs at the time of joining the trial.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: +86 15774917676
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
12-month survival rate
Can't join this trial?
Data last synced from ClinicalTrials.gov: 22 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.